267 related articles for article (PubMed ID: 22888000)
21. Porcn-dependent Wnt signaling is not required prior to mouse gastrulation.
Biechele S; Cockburn K; Lanner F; Cox BJ; Rossant J
Development; 2013 Jul; 140(14):2961-71. PubMed ID: 23760955
[TBL] [Abstract][Full Text] [Related]
22. Loss of Porcupine impairs convergent extension during gastrulation in zebrafish.
Chen Q; Takada R; Takada S
J Cell Sci; 2012 May; 125(Pt 9):2224-34. PubMed ID: 22357957
[TBL] [Abstract][Full Text] [Related]
23. PORCN moonlights in a Wnt-independent pathway that regulates cancer cell proliferation.
Covey TM; Kaur S; Tan Ong T; Proffitt KD; Wu Y; Tan P; Virshup DM
PLoS One; 2012; 7(4):e34532. PubMed ID: 22509316
[TBL] [Abstract][Full Text] [Related]
24. Importance of PORCN and Wnt signaling pathways in embryogenesis.
Clements SE
Am J Med Genet A; 2009 Sep; 149A(9):2050-1. PubMed ID: 19681149
[No Abstract] [Full Text] [Related]
25. A Novel PORCN Frameshift Mutation Leading to Focal Dermal Hypoplasia: A Case Report.
Durmaz CD; McGrath J; Liu L; Karabulut HG
Cytogenet Genome Res; 2018; 154(3):119-121. PubMed ID: 29525789
[TBL] [Abstract][Full Text] [Related]
26. Spatial and temporal expression of PORCN is highly dynamic in the developing mouse cochlea.
Oliver BL; Young CA; Munnamalai V
Gene Expr Patterns; 2021 Dec; 42():119214. PubMed ID: 34547456
[TBL] [Abstract][Full Text] [Related]
27. Suppression of Wnt/β-Catenin Signaling Is Associated with Downregulation of Wnt1, PORCN, and Rspo2 in Alzheimer's Disease.
Macyczko JR; Wang N; Zhao J; Ren Y; Lu W; Ikezu TC; Zhao N; Liu CC; Bu G; Li Y
Mol Neurobiol; 2023 Jan; 60(1):26-35. PubMed ID: 36215026
[TBL] [Abstract][Full Text] [Related]
28. Mutations in X-linked PORCN, a putative regulator of Wnt signaling, cause focal dermal hypoplasia.
Wang X; Reid Sutton V; Omar Peraza-Llanes J; Yu Z; Rosetta R; Kou YC; Eble TN; Patel A; Thaller C; Fang P; Van den Veyver IB
Nat Genet; 2007 Jul; 39(7):836-8. PubMed ID: 17546030
[TBL] [Abstract][Full Text] [Related]
29. PORCN mutations and variants identified in patients with focal dermal hypoplasia through diagnostic gene sequencing.
Fernandes PH; Wen S; Sutton VR; Ward PA; Van den Veyver IB; Fang P
Genet Test Mol Biomarkers; 2010 Oct; 14(5):709-13. PubMed ID: 20854095
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological inhibition of the Wnt acyltransferase PORCN prevents growth of WNT-driven mammary cancer.
Proffitt KD; Madan B; Ke Z; Pendharkar V; Ding L; Lee MA; Hannoush RN; Virshup DM
Cancer Res; 2013 Jan; 73(2):502-7. PubMed ID: 23188502
[TBL] [Abstract][Full Text] [Related]
31. The porcupine inhibitor WNT974 provokes ectodermal lineage differentiation of human embryonic stem cells.
Kalantary-Charvadeh A; Hosseini V; Mehdizadeh A; Nazari Soltan Ahmad S; Rahbarghazi R; Nozad Charoudeh H; Nouri M; Darabi M
Cell Biochem Funct; 2022 Jun; 40(4):359-368. PubMed ID: 35445405
[TBL] [Abstract][Full Text] [Related]
32. Responses of Porcupine and Wntless proteins to oxidative, hypoxic and endoplasmic reticulum stresses.
Mohamed R; Kennedy C; Willmore WG
Cell Signal; 2021 Sep; 85():110047. PubMed ID: 34015469
[TBL] [Abstract][Full Text] [Related]
33. Focal dermal hypoplasia resulting from a new nonsense mutation, p.E300X, in the PORCN gene.
Clements SE; Wessagowit V; Lai-Cheong JE; Arita K; McGrath JA
J Dermatol Sci; 2008 Jan; 49(1):39-42. PubMed ID: 17951029
[TBL] [Abstract][Full Text] [Related]
34. Novel PORCN inhibitor WHN-88 targets Wnt/β-catenin pathway and prevents the growth of Wnt-driven cancers.
Yang Q; Qin T; An T; Wu H; Xu G; Xiang J; Lei K; Zhang S; Xia J; Su G; Wang D; Xue M; Kong L; Zhang W; Wu S; Li Y
Eur J Pharmacol; 2023 Apr; 945():175628. PubMed ID: 36858339
[TBL] [Abstract][Full Text] [Related]
35. Discovery and Optimization of a Porcupine Inhibitor.
Duraiswamy AJ; Lee MA; Madan B; Ang SH; Tan ES; Cheong WW; Ke Z; Pendharkar V; Ding LJ; Chew YS; Manoharan V; Sangthongpitag K; Alam J; Poulsen A; Ho SY; Virshup DM; Keller TH
J Med Chem; 2015 Aug; 58(15):5889-99. PubMed ID: 26110200
[TBL] [Abstract][Full Text] [Related]
36. Diverse chemical scaffolds support direct inhibition of the membrane-bound O-acyltransferase porcupine.
Dodge ME; Moon J; Tuladhar R; Lu J; Jacob LS; Zhang LS; Shi H; Wang X; Moro E; Mongera A; Argenton F; Karner CM; Carroll TJ; Chen C; Amatruda JF; Lum L
J Biol Chem; 2012 Jun; 287(27):23246-54. PubMed ID: 22593577
[TBL] [Abstract][Full Text] [Related]
37. Focal dermal hypoplasia without focal dermal hypoplasia.
Contreras-Capetillo SN; Lombardi MP; Pinto-Escalante D; Hennekam RC
Am J Med Genet A; 2014 Mar; 164A(3):778-81. PubMed ID: 24357603
[TBL] [Abstract][Full Text] [Related]
38. Modulating Wnt signaling at the root: Porcupine and Wnt acylation.
Torres VI; Godoy JA; Inestrosa NC
Pharmacol Ther; 2019 Jun; 198():34-45. PubMed ID: 30790642
[TBL] [Abstract][Full Text] [Related]
39. Genetically engineered mouse models to evaluate the role of Wnt secretion in bone development and homeostasis.
Williams BO
Am J Med Genet C Semin Med Genet; 2016 Mar; 172C(1):24-6. PubMed ID: 26818176
[TBL] [Abstract][Full Text] [Related]
40. A nonsense porcn mutation in severe focal dermal hypoplasia with natal teeth.
Dias C; Basto J; Pinho O; Barbêdo C; Mártins M; Bornholdt D; Fortuna A; Grzeschik KH; Lima M
Fetal Pediatr Pathol; 2010; 29(5):305-13. PubMed ID: 20704476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
